Merdury Biopharmaceutical Corporation (TPEX:6932)
5.86
-0.06 (-1.01%)
Oct 20, 2026, 1:50 PM CST
| Market Cap | 2.38B +3.1% |
| Revenue (ttm) | n/a |
| Net Income | -51.62M |
| EPS | -0.12 |
| Shares Out | 403.46M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 116,864 |
| Open | 5.92 |
| Previous Close | 5.92 |
| Day's Range | 5.86 - 6.14 |
| 52-Week Range | 4.71 - 12.20 |
| Beta | -1.15 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |